Italia markets open in 8 hours 56 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
62,46-0,15 (-0,24%)
Alla chiusura: 04:00PM EST
62,44 -0,02 (-0,03%)
Dopo ore: 05:58PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente62,61
Aperto62,24
Denaro61,61 x 1400
Lettera62,79 x 800
Min-Max giorno61,45 - 62,81
Intervallo di 52 settimane53,22 - 69,75
Volume9.773.679
Media Volume13.440.354
Capitalizzazione140,699B
Beta (5 anni mensile)0,63
Rapporto PE (ttm)N/D
EPS (ttm)-2,42
Prossima data utili04 feb 2022
Rendimento e dividendo (forward)2,16 (3,34%)
Data ex dividendo06 gen 2022
Stima target 1A72,13
  • GlobeNewswire

    INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of BMY, LSPD, PTON, ZG Investors, Lead Plaintiff Deadlines Set

    NEW ORLEANS, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Bristol-Myers Squibb Company (BMY)Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares of Celgene Corporation (CELG) pursuant to Bristol-Myers’ acquisition of Celgene on November 20, 2019Lead Plaintiff Motion

  • GlobeNewswire

    FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, CTXS, HEPS and STNE

    CEDARHURST, N.Y., Nov. 30, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. Bristol-Myers Squibb Company (BMY)Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares of Celgene Corporation (CELG) pursuant to Bristol-Myers’ acquisition of Celgene on November 20, 2019Lead Plaintiff Motion Deadline: December 6, 2021MISLEADING PROSPECTUS To learn

  • GlobeNewswire

    SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMY, OWLT, PTON, ZG INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

    NEW ORLEANS, Nov. 29, 2021 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Bristol-Myers Squibb Company (BMY)Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares of Celgene Corporation (CELG) pursuant to Bristol-Myers’ acquisition of Celgene on November 20, 2019Lead Plaintiff Motion Deadline: December 6, 2021MISLEADING PROSPECTUS To le